STAGE IB BREAST CANCER AJCC V7
Clinical trials for STAGE IB BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Proton beam radiation aims to spare healthy tissue in breast cancer treatment
Disease control OngoingThis phase II trial is testing a type of radiation called proton beam therapy for women with early-stage breast cancer (stage 0 to II). The goal is to see if this targeted approach can kill cancer cells while causing less damage to normal tissue, leading to fewer side effects and…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New radiation approach aims to cut side effects for breast cancer patients
Disease control TerminatedThis study tests a type of radiation called hypofractionated partial breast irradiation for women with early-stage breast cancer. Instead of treating the whole breast, it targets only the area where the cancer was removed, using higher doses over fewer sessions. The goal is to se…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
Could a gel help fight breast cancer? early trial underway
Disease control OngoingThis early-phase trial is testing whether a gel form of the drug endoxifen can be safely applied to the skin in women scheduled for breast surgery. The study includes 32 women with various stages of breast cancer or high genetic risk. Researchers are checking for skin reactions a…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Landmark study spares thousands of women from unnecessary chemo
Disease control OngoingThis large study looked at over 10,000 women with early-stage, hormone-sensitive breast cancer that had not spread to lymph nodes. It used a genetic test called Oncotype DX to see who could safely skip chemotherapy and just take hormone therapy. The goal was to find the best trea…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
Can acupuncture ease breast cancer pain? new trial investigates
Symptom relief OngoingThis phase 2 trial tests whether electroacupuncture can reduce chronic pain in women who have completed treatment for stage I-III breast cancer. 111 participants will receive either real acupuncture, sham acupuncture, or no treatment. The goal is to see if this gentle needle ther…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
Could 3 weeks of radiation be as good as 5 for breast cancer?
Symptom relief OngoingThis study compares a 3-week course of radiation to the standard 5-week course for breast cancer patients who need radiation to the lymph nodes. The goal is to see if the shorter schedule is just as effective at preventing cancer from coming back, while causing less arm swelling …
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 22, 2026 12:01 UTC
-
Shorter radiation may mean better cosmetics for breast cancer patients
Symptom relief OngoingThis study tested whether a shorter course of higher-dose radiation (hypofractionated) works as well as standard radiation for early-stage breast cancer. About 300 women with ductal carcinoma in situ or early invasive breast cancer took part. The goal was to see if the shorter tr…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC